SCHEMBL7780288

SCHEMBL7780288

NCCN1CCN(c2nc3ccccc3s2)CC1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.70
NPC1 O15118 7/20 0.70
SMN1; SMN2 Q16637 2/20 0.70
CYP1A2 P05177 2/20 0.70
CYP2D6 P10635 2/20 0.70
CYP2C9 P11712 2/20 0.70
CYP2C19 P33261 2/20 0.70
POLB P06746 1/20 0.70
MEN1 O00255 4/20 0.67
KMT2A Q03164 4/20 0.67
DRD4 P21917 1/20 0.60
GRM2 Q14416 1/20 0.60
USP2 O75604 1/20 0.59
GAA P10253 1/20 0.59
TSHR P16473 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
LMNA P02545 1/20 0.55
MAPT P10636 1/20 0.55
CYP3A4 P08684 1/20 0.54
SORD Q00796 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7534676 0.83 RAB9A (0.67) RAB9ANPC1SMN1; SMN2CYP1A2CYP2D6
SCHEMBL15941384 0.83 RAB9A (0.67) RAB9ANPC1SMN1; SMN2CYP1A2CYP2D6
SCHEMBL3157852 0.82 RAB9A (1.00) RAB9ANPC1SMN1; SMN2CYP1A2CYP2D6
SCHEMBL23965748 0.82 RAB9A (0.69) RAB9ANPC1SMN1; SMN2CYP1A2CYP2D6
SCHEMBL6125228 0.80 RAB9A (0.70) RAB9ANPC1SMN1; SMN2CYP1A2CYP2D6
SCHEMBL7760900 0.80 RAB9A (1.00) RAB9ANPC1SMN1; SMN2CYP1A2CYP2D6
SCHEMBL28142588 0.79 RAB9A (0.72) RAB9ANPC1SMN1; SMN2CYP1A2CYP2D6
SCHEMBL27652569 0.79 RAB9A (0.72) RAB9ANPC1SMN1; SMN2CYP1A2CYP2D6
SCHEMBL15086770 0.79 RAB9A (0.68) RAB9ANPC1SMN1; SMN2CYP1A2CYP2D6
SCHEMBL8526236 0.78 RAB9A (0.73) RAB9ANPC1SMN1; SMN2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0802196-B1 Alkylenediamine derivatives as drugs for the treatment of ulcers and the inhibition of Helicobacter pylori SHISEIDO CO LTD (JP) 2001-08-29 EP disclosed
EP-0802196-A1 Alkylenediamine derivative, antiulcer drug, and antibacterial drug SHISEIDO COMPANY LIMITED (JP) 1997-10-22 EP disclosed